Stockscreener 앱 받기
6.74
13.47%
0.80
시간 외 거래:
6.76
0.02
+0.30%
전일 마감가:
$5.94
열려 있는:
$6
하루 거래량:
2.16M
Relative Volume:
0.88
시가총액:
$308.13M
수익:
$27.10M
순이익/손실:
$-24.31M
주가수익비율:
-8.1205
EPS:
-0.83
순현금흐름:
$-33.33M
1주 성능:
+7.32%
1개월 성능:
-12.13%
6개월 성능:
-46.72%
1년 성능:
+58.96%
1일 변동 폭
$5.8196
$6.7677
1주일 범위
$5.68
$6.7677
52주 변동 폭
$3.98
$23.40
Capricor Therapeutics Inc Stock (CAPR) Company Profile
명칭
Capricor Therapeutics Inc
전화
(310) 358-3200
주소
10865 ROAD TO THE CURE, SAN DIEGO, CA
CAPR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CAPR
Capricor Therapeutics Inc
|
6.74 | 271.56M | 27.10M | -24.31M | -33.33M | -0.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Capricor Therapeutics Inc Stock (CAPR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-30 | 개시 | Alliance Global Partners | Buy |
| 2025-06-26 | 개시 | B. Riley Securities | Buy |
| 2025-05-20 | 개시 | Roth Capital | Buy |
| 2024-10-21 | 개시 | Piper Sandler | Overweight |
| 2024-05-17 | 개시 | Oppenheimer | Outperform |
| 2024-01-05 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-10-26 | 개시 | Ladenburg Thalmann | Buy |
| 2018-12-26 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2018-01-26 | 재확인 | H.C. Wainwright | Buy |
| 2017-09-15 | 재확인 | H.C. Wainwright | Buy |
| 2017-02-13 | 재개 | Rodman & Renshaw | Buy |
| 2016-07-06 | 재개 | H.C. Wainwright | Buy |
| 2016-06-15 | 개시 | ROTH Capital | Buy |
모두보기
Capricor Therapeutics Inc 주식(CAPR)의 최신 뉴스
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics - The Malaysian Reserve
Can Capricor Therapeutics Inc. stock double in the next yearJuly 2025 Spike Watch & Comprehensive Market Scan Insights - خودرو بانک
Capricor Therapeutics, Inc. Investors: Please contact the - GlobeNewswire
CAPR FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, - GlobeNewswire
CAPR FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 15 Deadline in Securities Class Action – CAPR - GlobeNewswire Inc.
Capricor Therapeutics, Inc. Class Action: Levi & Korsinsky - GlobeNewswire
Short interest data insights for Capricor Therapeutics Inc.Quarterly Portfolio Review & Weekly Hot Stock Watchlists - Newser
Join Class Action to Recover Losses from Capricor Therapeutics, Inc. (CAPR)Contact Levi & Korsinsky Before September 15, 2025 - Barchart.com
CAPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Morningstar
CAPR LAWSUIT ALERT: The Gross Law Firm Notifies Capricor Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MarketScreener
CAPR Deadline: CAPR Investors with Losses in Excess of $100K Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit - Morningstar
What is the long term forecast for Capricor Therapeutics Inc. stock2025 Trading Recap & Verified Entry Point Signals - خودرو بانک
Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investor Alert: Deadline in Lawsuit on September 15, 2025 - openPR.com
Class Action Lawsuit Filed Against Capricor Therapeutics, Inc. (CAPR)Recover LossesContact Levi & Korsinsky Before September 15, 2025 - Barchart.com
How much upside does Capricor Therapeutics Inc. haveWeekly Gains Report & Weekly Market Pulse Updates - خودرو بانک
Tools to assess Capricor Therapeutics Inc.’s risk profileMarket Growth Report & Growth Oriented Trade Recommendations - Newser
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics - Morningstar
CAPRICOR ALERT: Bragar Eagel & Squire, P.C. Announces that - GlobeNewswire
4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past Week - Benzinga
Volatility clustering patterns for Capricor Therapeutics Inc.Market Volume Summary & Technical Pattern Alert System - Newser
Nuveen LLC Acquires Shares of 89,141 Capricor Therapeutics, Inc. $CAPR - Defense World
Long term hold vs stop loss in Capricor Therapeutics Inc.Weekly Profit Report & Expert Curated Trade Setup Alerts - Newser
Can Capricor Therapeutics Inc. disrupt its industryJuly 2025 Chart Watch & High Yield Stock Recommendations - خودرو بانک
Real time social sentiment graph for Capricor Therapeutics Inc.2025 Major Catalysts & Fast Gain Swing Trade Alerts - Newser
מועד אחרון לתביעה נגד CAPR: רוזן, משרד עורכי דין מהימן ומוביל, מעודד משקיעים ב- Capricor Therapeutics, Inc. עם הפסדים של יותר מ-100 אלף דולר להבטיח ייעוץ לפני המועד האחרון החשוב בתביעה ייצוגית בניירות ערך - GlobeNewswire Inc.
Chart based exit strategy for Capricor Therapeutics Inc.Earnings Growth Report & Free Community Consensus Stock Picks - Newser
How to forecast Capricor Therapeutics Inc. trends using time seriesJuly 2025 EndofMonth & Capital Protection Trading Alerts - Newser
INVESTOR ALERT: Holzer & Holzer, LLC Reminds Investors of - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc.CAPR - Morningstar
CAPRICOR THERAPEUTICS, INC. (NASDAQ: CAPR) SHAREHOLDER - GlobeNewswire
Levi & Korsinsky Notifies Shareholders of Capricor Therapeutics, Inc.(CAPR) of a Class Action Lawsuit and an Upcoming Deadline - PR Newswire
Market Overview: Can Capricor Therapeutics Inc. expand into new marketsJuly 2025 Macro Moves & Free Community Consensus Stock Picks - خودرو بانک
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar
Capricor Therapeutics, Inc. $CAPR Shares Bought by Charles Schwab Investment Management Inc. - Defense World
Will Capricor Therapeutics Inc. outperform the marketJuly 2025 Price Swings & Verified Entry Point Signals - Newser
Detecting support and resistance levels for Capricor Therapeutics Inc.July 2025 Trends & Free Low Drawdown Momentum Trade Ideas - Newser
CAPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
CAPR Lawsuit Alert! Class Action Lawsuit Against Capricor Therapeutics - TipRanks
Combining machine learning predictions for Capricor Therapeutics Inc.Portfolio Risk Summary & Real-Time Market Sentiment Reports - Newser
Capricor Therapeutics Faces Challenges Despite Strong Cash Position - TipRanks
Multi factor analysis applied to Capricor Therapeutics Inc.July 2025 Catalysts & Entry and Exit Point Strategies - Newser
CAPR DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages - GlobeNewswire
Bragar Eagel & Squire, P.C. Urges Investors in XPLR - GlobeNewswire
Deutsche Bank AG Has $272,000 Position in Capricor Therapeutics, Inc. $CAPR - Defense World
Vanguard Group Inc. Reduces Stock Holdings in Capricor Therapeutics, Inc. $CAPR - Defense World
Is Capricor Therapeutics Inc. forming a bottoming baseJobs Report & Fast Entry Momentum Trade Alerts - Newser
Capricor Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. September 15, 2025 Deadline to file Lead Plaintiff Motion. - GlobeNewswire
Capricor Therapeutics Inc (CAPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Capricor Therapeutics Inc 주식 (CAPR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Bergmann Anthony | CHIEF FINANCIAL OFFICER |
Mar 03 '25 |
Option Exercise |
1.39 |
2,500 |
3,475 |
8,223 |
| Litvack Frank | Director |
Mar 03 '25 |
Option Exercise |
1.39 |
25,000 |
34,750 |
132,382 |
| DUNBAR GEORGE W JR | Director |
Mar 03 '25 |
Option Exercise |
1.39 |
750 |
1,042 |
11,306 |
| COLLIER EARL M JR | Director |
Feb 27 '25 |
Option Exercise |
1.39 |
750 |
1,042 |
57,606 |
| Krasney Karen | EVP, GENERAL COUNSEL |
Dec 13 '24 |
Option Exercise |
1.39 |
8,000 |
11,120 |
28,047 |
| Litvack Frank | Director |
Dec 03 '24 |
Option Exercise |
1.10 |
20,391 |
22,430 |
46,278 |
| Nippon Shinyaku Co Ltd | 10% Owner |
Sep 20 '24 |
Buy |
5.36 |
2,798,507 |
14,999,998 |
7,090,351 |
1.40%
자본화:
|
볼륨(24시간):